随着全球变暖导致的问题日趋严重，我国提出了2030年碳达峰、2060年碳中和的“3060双碳目标”。目前，中药制药行业缺乏相应的碳排放评价方法与碳足迹核算模型，难以精准指导制药工艺改进与新技术、新装备节能评价，成为中药绿色制药需要解决的首要问题。因此，基于碳足迹概念，初步提出中药制药行业的碳足迹核算方法，梳理了碳排放较多的制药工艺环节，并以根类中药饮片和中药口服液的生产为例简述其核算要素，以期全面统计和分析中药制药行业的碳排放，为中药制药企业的绿色制造与节能减排提供参考。

As the problems caused by global warming become more and more serious, China has proposed the “3060 double carbon target” of reaching the carbon peak by 2030 and becoming carbon neutral in 2060. At present, traditional Chinese medicine pharmaceutical industries lack corresponding carbon emission evaluation methods and carbon footprint accounting models, which make it difficult to accurately guide pharmaceutical process improvement and energy-saving evaluation of new technologies and equipment, making it the primary problem that needs to be solved for green pharmaceuticals in traditional Chinese medicine. Therefore, based on the concept of carbon footprint, a carbon footprint accounting method for traditional Chinese medicine pharmaceutical industry was initially proposed in this paper, the pharmaceutical processes with high carbon emissions were sorted out. The accounting elements for the production of root traditional Chinese medicine tablets and traditional Chinese medicine oral liquids were briefly described as examples, in order to comprehensively count and analyze the carbon emissions of traditional Chinese medicine pharmaceutical industry, and provide a reference for green manufacturing and energy conservation and emission reduction of traditional Chinese medicine manufacturing companies.

R288

四川省科技计划资助项目(2022YFS0431)